Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next
15 January 2026
1 min read

Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

New York, Jan 15, 2026, 16:57 EST — After-hours

  • Strategy dropped 4.7% Thursday, dragged down by a late sell-off in bitcoin and retreat in crypto-related stocks
  • A U.S. Senate committee delayed discussion on a crypto market-structure bill following objections from Coinbase’s CEO to the draft
  • Strategy scheduled for Feb. 5, following the release of fourth-quarter results after the close

Strategy Inc (MSTR) shares ended Thursday down 4.7%, settling at $170.91. The stock saw a brief early rally that fizzled out by the closing bell, and it showed minimal movement in after-hours trading.

This is significant since the stock has behaved less like a typical software play and more like a high-beta stand-in for bitcoin, which dropped roughly 2% late Thursday following a brief rally.

The U.S. Senate Banking Committee delayed its scheduled markup—a key session to debate and vote on amendments—of a bill aimed at establishing a regulatory framework for crypto markets. Coinbase CEO Brian Armstrong weighed in on X, saying the exchange cannot back the draft in its current form. “We’d rather have no bill than a bad bill,” he stated. 1

Strategy, headquartered in Tysons Corner, Virginia, plans to release its fourth-quarter 2025 results after U.S. markets close on Thursday, Feb. 5. The company will also host a live video webinar at 5 p.m. Eastern to review the financials. 2

Shares tied to crypto took a hit, with Coinbase sliding 6.5% and Robinhood down 7.8%.

Strategy’s internal records indicate it owns 687,410 bitcoin, bought for roughly $51.8 billion, averaging $75,353 per coin. 3

The firm, once known as MicroStrategy, also offers enterprise analytics software. Yet it’s the bitcoin holdings — and the financing behind them — that usually drive the stock’s daily moves. 4

The risk is straightforward: Washington could prolong the standoff, while bitcoin’s price might swing sharply. If the token falls further, it could put Strategy shares under pressure right as they approach their next earnings report.

Traders will keep an eye on bitcoin Friday to see if it holds steady following the bill’s delay, while lawmakers weigh in on a potential new schedule for the stalled markup.

The next key event arrives Feb. 5, when Strategy releases its earnings after the market closes. Investors will get an updated look at its bitcoin approach and the underlying balance-sheet figures.

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, rebounding after a 13% plunge earlier in the week on weak guidance and AI competition fears. The Philadelphia semiconductor index rose 5.7% as chip stocks led a broader market rally. Investors are awaiting next week’s U.S. payrolls and inflation data, which could shift rate expectations for tech.
Eli Lilly stock slides after FDA pushes obesity pill decision to April 10
Previous Story

Eli Lilly stock slides after FDA pushes obesity pill decision to April 10

Morgan Stanley stock jumps nearly 6% after earnings beat as deal fees rebound
Next Story

Morgan Stanley stock jumps nearly 6% after earnings beat as deal fees rebound

Go toTop